利索-全球专利检索

  1. 登录
  2. 注册
发明申请
US20110052576A1 VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS 审中-公开
VEGF特异性拮抗剂用于治疗和治疗早期治疗和早期阶段肿瘤

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS
摘要：
Disclosed herein are methods of treating benign, pre-cancerous, or non-metastatic tumors using an anti-VEGF-specific antagonist. Also disclosed are methods of treating a subject at risk of developing benign, pre-cancerous, or non-metastatic tumors using an anti-VEGF-specific antagonist. Also disclosed are methods of treating or preventing recurrence of a tumor using an anti-VEGF-specific antagonist as well as use of VEGF-specific antagonists in neoadjuvant and adjuvant cancer therapy.
摘要（中）：

本文公开了使用抗VEGF特异性拮抗剂治疗良性，癌前或非转移性肿瘤的方法。 还公开了使用抗VEGF特异性拮抗剂治疗患有发展良性，癌前或非转移性肿瘤的风险的受试者的方法。 还公开了使用抗VEGF特异性拮抗剂治疗或预防肿瘤复发以及在新辅助和辅助癌症治疗中使用VEGF特异性拮抗剂的方法。

信息查询
Global Dossier Espacenet
0/0